nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A2—Cisplatin—bone cancer	0.428	0.642	CbGbCtD
Famotidine—SLC22A8—Methotrexate—bone cancer	0.238	0.358	CbGbCtD
Famotidine—Jaundice cholestatic—Doxorubicin—bone cancer	0.00206	0.00618	CcSEcCtD
Famotidine—Atrioventricular block—Epirubicin—bone cancer	0.00202	0.00605	CcSEcCtD
Famotidine—Viral infection—Doxorubicin—bone cancer	0.00201	0.00602	CcSEcCtD
Famotidine—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00201	0.00602	CcSEcCtD
Famotidine—Neck pain—Epirubicin—bone cancer	0.00198	0.00594	CcSEcCtD
Famotidine—Musculoskeletal pain—Epirubicin—bone cancer	0.00198	0.00594	CcSEcCtD
Famotidine—Bradycardia—Cisplatin—bone cancer	0.00195	0.00585	CcSEcCtD
Famotidine—Influenza like illness—Epirubicin—bone cancer	0.0019	0.0057	CcSEcCtD
Famotidine—Gynaecomastia—Methotrexate—bone cancer	0.00187	0.00562	CcSEcCtD
Famotidine—Atrioventricular block—Doxorubicin—bone cancer	0.00187	0.0056	CcSEcCtD
Famotidine—Musculoskeletal pain—Doxorubicin—bone cancer	0.00183	0.0055	CcSEcCtD
Famotidine—Neck pain—Doxorubicin—bone cancer	0.00183	0.0055	CcSEcCtD
Famotidine—Tinnitus—Cisplatin—bone cancer	0.00179	0.00535	CcSEcCtD
Famotidine—Flushing—Cisplatin—bone cancer	0.00178	0.00533	CcSEcCtD
Famotidine—Influenza like illness—Doxorubicin—bone cancer	0.00176	0.00528	CcSEcCtD
Famotidine—Photosensitivity—Methotrexate—bone cancer	0.00173	0.00519	CcSEcCtD
Famotidine—Arrhythmia—Cisplatin—bone cancer	0.00171	0.00513	CcSEcCtD
Famotidine—Alopecia—Cisplatin—bone cancer	0.00169	0.00508	CcSEcCtD
Famotidine—Photosensitivity—Epirubicin—bone cancer	0.00162	0.00486	CcSEcCtD
Famotidine—Muscle spasms—Cisplatin—bone cancer	0.0016	0.00481	CcSEcCtD
Famotidine—Anaemia—Cisplatin—bone cancer	0.00154	0.00462	CcSEcCtD
Famotidine—Photosensitivity—Doxorubicin—bone cancer	0.0015	0.00449	CcSEcCtD
Famotidine—Leukopenia—Cisplatin—bone cancer	0.00149	0.00448	CcSEcCtD
Famotidine—Irritability—Methotrexate—bone cancer	0.00145	0.00435	CcSEcCtD
Famotidine—Convulsion—Cisplatin—bone cancer	0.00144	0.00433	CcSEcCtD
Famotidine—Pain in extremity—Epirubicin—bone cancer	0.00142	0.00426	CcSEcCtD
Famotidine—Myalgia—Cisplatin—bone cancer	0.00142	0.00426	CcSEcCtD
Famotidine—Anxiety—Cisplatin—bone cancer	0.00141	0.00424	CcSEcCtD
Famotidine—Migraine—Epirubicin—bone cancer	0.0014	0.0042	CcSEcCtD
Famotidine—Face oedema—Epirubicin—bone cancer	0.00137	0.00412	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00137	0.0041	CcSEcCtD
Famotidine—Anaphylactic shock—Cisplatin—bone cancer	0.00136	0.00408	CcSEcCtD
Famotidine—Oedema—Cisplatin—bone cancer	0.00136	0.00408	CcSEcCtD
Famotidine—Infection—Cisplatin—bone cancer	0.00135	0.00405	CcSEcCtD
Famotidine—Thrombocytopenia—Cisplatin—bone cancer	0.00133	0.004	CcSEcCtD
Famotidine—Pain in extremity—Doxorubicin—bone cancer	0.00132	0.00394	CcSEcCtD
Famotidine—Dry skin—Epirubicin—bone cancer	0.0013	0.00391	CcSEcCtD
Famotidine—Anorexia—Cisplatin—bone cancer	0.0013	0.00389	CcSEcCtD
Famotidine—Migraine—Doxorubicin—bone cancer	0.00129	0.00388	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00128	0.00384	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00128	0.00384	CcSEcCtD
Famotidine—Face oedema—Doxorubicin—bone cancer	0.00127	0.00381	CcSEcCtD
Famotidine—Abdominal discomfort—Methotrexate—bone cancer	0.00126	0.00377	CcSEcCtD
Famotidine—Pancytopenia—Methotrexate—bone cancer	0.00125	0.00374	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00124	0.00372	CcSEcCtD
Famotidine—Influenza—Epirubicin—bone cancer	0.00123	0.00368	CcSEcCtD
Famotidine—Dysuria—Methotrexate—bone cancer	0.00123	0.00368	CcSEcCtD
Famotidine—Neutropenia—Methotrexate—bone cancer	0.00123	0.00368	CcSEcCtD
Famotidine—Paraesthesia—Cisplatin—bone cancer	0.00122	0.00366	CcSEcCtD
Famotidine—Upper respiratory tract infection—Methotrexate—bone cancer	0.00122	0.00366	CcSEcCtD
Famotidine—Erectile dysfunction—Methotrexate—bone cancer	0.00121	0.00363	CcSEcCtD
Famotidine—Dry skin—Doxorubicin—bone cancer	0.00121	0.00362	CcSEcCtD
Famotidine—Photosensitivity reaction—Methotrexate—bone cancer	0.0012	0.00359	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00118	0.00355	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00118	0.00355	CcSEcCtD
Famotidine—Decreased appetite—Cisplatin—bone cancer	0.00118	0.00355	CcSEcCtD
Famotidine—Bronchitis—Epirubicin—bone cancer	0.00118	0.00354	CcSEcCtD
Famotidine—Depression—Methotrexate—bone cancer	0.00117	0.0035	CcSEcCtD
Famotidine—Pancytopenia—Epirubicin—bone cancer	0.00117	0.0035	CcSEcCtD
Famotidine—Pain—Cisplatin—bone cancer	0.00116	0.00349	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00116	0.00348	CcSEcCtD
Famotidine—Dysuria—Epirubicin—bone cancer	0.00115	0.00345	CcSEcCtD
Famotidine—Neutropenia—Epirubicin—bone cancer	0.00115	0.00345	CcSEcCtD
Famotidine—Upper respiratory tract infection—Epirubicin—bone cancer	0.00114	0.00342	CcSEcCtD
Famotidine—Influenza—Doxorubicin—bone cancer	0.00114	0.00341	CcSEcCtD
Famotidine—Pollakiuria—Epirubicin—bone cancer	0.00113	0.0034	CcSEcCtD
Famotidine—Photosensitivity reaction—Epirubicin—bone cancer	0.00112	0.00336	CcSEcCtD
Famotidine—Feeling abnormal—Cisplatin—bone cancer	0.00112	0.00336	CcSEcCtD
Famotidine—Haematuria—Methotrexate—bone cancer	0.00112	0.00335	CcSEcCtD
Famotidine—Bronchitis—Doxorubicin—bone cancer	0.00109	0.00328	CcSEcCtD
Famotidine—Agranulocytosis—Methotrexate—bone cancer	0.00109	0.00328	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00109	0.00326	CcSEcCtD
Famotidine—Pancytopenia—Doxorubicin—bone cancer	0.00108	0.00324	CcSEcCtD
Famotidine—Body temperature increased—Cisplatin—bone cancer	0.00108	0.00323	CcSEcCtD
Famotidine—Jaundice—Epirubicin—bone cancer	0.00107	0.0032	CcSEcCtD
Famotidine—Dysuria—Doxorubicin—bone cancer	0.00106	0.00319	CcSEcCtD
Famotidine—Neutropenia—Doxorubicin—bone cancer	0.00106	0.00319	CcSEcCtD
Famotidine—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00106	0.00317	CcSEcCtD
Famotidine—Hepatitis—Methotrexate—bone cancer	0.00105	0.00315	CcSEcCtD
Famotidine—Pollakiuria—Doxorubicin—bone cancer	0.00105	0.00315	CcSEcCtD
Famotidine—Haematuria—Epirubicin—bone cancer	0.00104	0.00313	CcSEcCtD
Famotidine—Pharyngitis—Methotrexate—bone cancer	0.00104	0.00313	CcSEcCtD
Famotidine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00104	0.00311	CcSEcCtD
Famotidine—Sinusitis—Epirubicin—bone cancer	0.00103	0.00308	CcSEcCtD
Famotidine—Agranulocytosis—Epirubicin—bone cancer	0.00102	0.00307	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.001	0.00301	CcSEcCtD
Famotidine—Hypersensitivity—Cisplatin—bone cancer	0.001	0.00301	CcSEcCtD
Famotidine—Bradycardia—Epirubicin—bone cancer	0.001	0.003	CcSEcCtD
Famotidine—Erythema multiforme—Methotrexate—bone cancer	0.000993	0.00298	CcSEcCtD
Famotidine—Jaundice—Doxorubicin—bone cancer	0.000988	0.00296	CcSEcCtD
Famotidine—Hepatitis—Epirubicin—bone cancer	0.000983	0.00295	CcSEcCtD
Famotidine—Tinnitus—Methotrexate—bone cancer	0.00098	0.00294	CcSEcCtD
Famotidine—Asthenia—Cisplatin—bone cancer	0.000976	0.00293	CcSEcCtD
Famotidine—Pharyngitis—Epirubicin—bone cancer	0.000976	0.00293	CcSEcCtD
Famotidine—Haematuria—Doxorubicin—bone cancer	0.000966	0.0029	CcSEcCtD
Famotidine—Sinusitis—Doxorubicin—bone cancer	0.000951	0.00285	CcSEcCtD
Famotidine—Agranulocytosis—Doxorubicin—bone cancer	0.000946	0.00284	CcSEcCtD
Famotidine—Diarrhoea—Cisplatin—bone cancer	0.000931	0.00279	CcSEcCtD
Famotidine—Erythema multiforme—Epirubicin—bone cancer	0.00093	0.00279	CcSEcCtD
Famotidine—Alopecia—Methotrexate—bone cancer	0.000928	0.00279	CcSEcCtD
Famotidine—Bradycardia—Doxorubicin—bone cancer	0.000926	0.00278	CcSEcCtD
Famotidine—Mental disorder—Methotrexate—bone cancer	0.000921	0.00276	CcSEcCtD
Famotidine—Tinnitus—Epirubicin—bone cancer	0.000917	0.00275	CcSEcCtD
Famotidine—Flushing—Epirubicin—bone cancer	0.000913	0.00274	CcSEcCtD
Famotidine—Hepatitis—Doxorubicin—bone cancer	0.00091	0.00273	CcSEcCtD
Famotidine—Pharyngitis—Doxorubicin—bone cancer	0.000903	0.00271	CcSEcCtD
Famotidine—Dysgeusia—Methotrexate—bone cancer	0.000896	0.00269	CcSEcCtD
Famotidine—Back pain—Methotrexate—bone cancer	0.000885	0.00265	CcSEcCtD
Famotidine—Arrhythmia—Epirubicin—bone cancer	0.000878	0.00263	CcSEcCtD
Famotidine—Alopecia—Epirubicin—bone cancer	0.000869	0.00261	CcSEcCtD
Famotidine—Vomiting—Cisplatin—bone cancer	0.000865	0.00259	CcSEcCtD
Famotidine—Mental disorder—Epirubicin—bone cancer	0.000861	0.00258	CcSEcCtD
Famotidine—Erythema multiforme—Doxorubicin—bone cancer	0.00086	0.00258	CcSEcCtD
Famotidine—Rash—Cisplatin—bone cancer	0.000858	0.00257	CcSEcCtD
Famotidine—Dermatitis—Cisplatin—bone cancer	0.000857	0.00257	CcSEcCtD
Famotidine—Tinnitus—Doxorubicin—bone cancer	0.000848	0.00254	CcSEcCtD
Famotidine—Anaemia—Methotrexate—bone cancer	0.000845	0.00254	CcSEcCtD
Famotidine—Flushing—Doxorubicin—bone cancer	0.000844	0.00253	CcSEcCtD
Famotidine—Dysgeusia—Epirubicin—bone cancer	0.000838	0.00251	CcSEcCtD
Famotidine—Back pain—Epirubicin—bone cancer	0.000828	0.00248	CcSEcCtD
Famotidine—Muscle spasms—Epirubicin—bone cancer	0.000823	0.00247	CcSEcCtD
Famotidine—Leukopenia—Methotrexate—bone cancer	0.000819	0.00246	CcSEcCtD
Famotidine—Arrhythmia—Doxorubicin—bone cancer	0.000813	0.00244	CcSEcCtD
Famotidine—Nausea—Cisplatin—bone cancer	0.000808	0.00242	CcSEcCtD
Famotidine—Alopecia—Doxorubicin—bone cancer	0.000804	0.00241	CcSEcCtD
Famotidine—Cough—Methotrexate—bone cancer	0.000798	0.00239	CcSEcCtD
Famotidine—Mental disorder—Doxorubicin—bone cancer	0.000797	0.00239	CcSEcCtD
Famotidine—Convulsion—Methotrexate—bone cancer	0.000792	0.00238	CcSEcCtD
Famotidine—Anaemia—Epirubicin—bone cancer	0.000791	0.00237	CcSEcCtD
Famotidine—Agitation—Epirubicin—bone cancer	0.000787	0.00236	CcSEcCtD
Famotidine—Arthralgia—Methotrexate—bone cancer	0.000779	0.00234	CcSEcCtD
Famotidine—Myalgia—Methotrexate—bone cancer	0.000779	0.00234	CcSEcCtD
Famotidine—Chest pain—Methotrexate—bone cancer	0.000779	0.00234	CcSEcCtD
Famotidine—Dysgeusia—Doxorubicin—bone cancer	0.000776	0.00233	CcSEcCtD
Famotidine—Syncope—Epirubicin—bone cancer	0.000768	0.0023	CcSEcCtD
Famotidine—Leukopenia—Epirubicin—bone cancer	0.000766	0.0023	CcSEcCtD
Famotidine—Back pain—Doxorubicin—bone cancer	0.000766	0.0023	CcSEcCtD
Famotidine—Muscle spasms—Doxorubicin—bone cancer	0.000761	0.00228	CcSEcCtD
Famotidine—Palpitations—Epirubicin—bone cancer	0.000756	0.00227	CcSEcCtD
Famotidine—Confusional state—Methotrexate—bone cancer	0.000753	0.00226	CcSEcCtD
Famotidine—Loss of consciousness—Epirubicin—bone cancer	0.000752	0.00226	CcSEcCtD
Famotidine—Cough—Epirubicin—bone cancer	0.000747	0.00224	CcSEcCtD
Famotidine—Anaphylactic shock—Methotrexate—bone cancer	0.000746	0.00224	CcSEcCtD
Famotidine—Convulsion—Epirubicin—bone cancer	0.000742	0.00222	CcSEcCtD
Famotidine—Infection—Methotrexate—bone cancer	0.000742	0.00222	CcSEcCtD
Famotidine—Anaemia—Doxorubicin—bone cancer	0.000732	0.0022	CcSEcCtD
Famotidine—Thrombocytopenia—Methotrexate—bone cancer	0.000731	0.00219	CcSEcCtD
Famotidine—Arthralgia—Epirubicin—bone cancer	0.000729	0.00219	CcSEcCtD
Famotidine—Myalgia—Epirubicin—bone cancer	0.000729	0.00219	CcSEcCtD
Famotidine—Chest pain—Epirubicin—bone cancer	0.000729	0.00219	CcSEcCtD
Famotidine—Agitation—Doxorubicin—bone cancer	0.000728	0.00218	CcSEcCtD
Famotidine—Anxiety—Epirubicin—bone cancer	0.000726	0.00218	CcSEcCtD
Famotidine—Dry mouth—Epirubicin—bone cancer	0.000713	0.00214	CcSEcCtD
Famotidine—Anorexia—Methotrexate—bone cancer	0.000712	0.00213	CcSEcCtD
Famotidine—Syncope—Doxorubicin—bone cancer	0.00071	0.00213	CcSEcCtD
Famotidine—Leukopenia—Doxorubicin—bone cancer	0.000709	0.00213	CcSEcCtD
Famotidine—Confusional state—Epirubicin—bone cancer	0.000704	0.00211	CcSEcCtD
Famotidine—Palpitations—Doxorubicin—bone cancer	0.0007	0.0021	CcSEcCtD
Famotidine—Anaphylactic shock—Epirubicin—bone cancer	0.000699	0.0021	CcSEcCtD
Famotidine—Oedema—Epirubicin—bone cancer	0.000699	0.0021	CcSEcCtD
Famotidine—Loss of consciousness—Doxorubicin—bone cancer	0.000696	0.00209	CcSEcCtD
Famotidine—Infection—Epirubicin—bone cancer	0.000694	0.00208	CcSEcCtD
Famotidine—Cough—Doxorubicin—bone cancer	0.000691	0.00207	CcSEcCtD
Famotidine—Shock—Epirubicin—bone cancer	0.000687	0.00206	CcSEcCtD
Famotidine—Convulsion—Doxorubicin—bone cancer	0.000686	0.00206	CcSEcCtD
Famotidine—Thrombocytopenia—Epirubicin—bone cancer	0.000684	0.00205	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00068	0.00204	CcSEcCtD
Famotidine—Insomnia—Methotrexate—bone cancer	0.000675	0.00203	CcSEcCtD
Famotidine—Chest pain—Doxorubicin—bone cancer	0.000674	0.00202	CcSEcCtD
Famotidine—Arthralgia—Doxorubicin—bone cancer	0.000674	0.00202	CcSEcCtD
Famotidine—Myalgia—Doxorubicin—bone cancer	0.000674	0.00202	CcSEcCtD
Famotidine—Anxiety—Doxorubicin—bone cancer	0.000672	0.00202	CcSEcCtD
Famotidine—Paraesthesia—Methotrexate—bone cancer	0.00067	0.00201	CcSEcCtD
Famotidine—Anorexia—Epirubicin—bone cancer	0.000666	0.002	CcSEcCtD
Famotidine—Somnolence—Methotrexate—bone cancer	0.000664	0.00199	CcSEcCtD
Famotidine—Dry mouth—Doxorubicin—bone cancer	0.000659	0.00198	CcSEcCtD
Famotidine—Dyspepsia—Methotrexate—bone cancer	0.000657	0.00197	CcSEcCtD
Famotidine—Confusional state—Doxorubicin—bone cancer	0.000652	0.00195	CcSEcCtD
Famotidine—Decreased appetite—Methotrexate—bone cancer	0.000649	0.00195	CcSEcCtD
Famotidine—Anaphylactic shock—Doxorubicin—bone cancer	0.000646	0.00194	CcSEcCtD
Famotidine—Oedema—Doxorubicin—bone cancer	0.000646	0.00194	CcSEcCtD
Famotidine—Fatigue—Methotrexate—bone cancer	0.000644	0.00193	CcSEcCtD
Famotidine—Infection—Doxorubicin—bone cancer	0.000642	0.00193	CcSEcCtD
Famotidine—Pain—Methotrexate—bone cancer	0.000638	0.00191	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000636	0.00191	CcSEcCtD
Famotidine—Shock—Doxorubicin—bone cancer	0.000636	0.00191	CcSEcCtD
Famotidine—Thrombocytopenia—Doxorubicin—bone cancer	0.000633	0.0019	CcSEcCtD
Famotidine—Insomnia—Epirubicin—bone cancer	0.000632	0.0019	CcSEcCtD
Famotidine—Paraesthesia—Epirubicin—bone cancer	0.000627	0.00188	CcSEcCtD
Famotidine—Somnolence—Epirubicin—bone cancer	0.000621	0.00186	CcSEcCtD
Famotidine—Anorexia—Doxorubicin—bone cancer	0.000616	0.00185	CcSEcCtD
Famotidine—Feeling abnormal—Methotrexate—bone cancer	0.000615	0.00185	CcSEcCtD
Famotidine—Dyspepsia—Epirubicin—bone cancer	0.000615	0.00184	CcSEcCtD
Famotidine—Gastrointestinal pain—Methotrexate—bone cancer	0.00061	0.00183	CcSEcCtD
Famotidine—Decreased appetite—Epirubicin—bone cancer	0.000607	0.00182	CcSEcCtD
Famotidine—Fatigue—Epirubicin—bone cancer	0.000602	0.00181	CcSEcCtD
Famotidine—Pain—Epirubicin—bone cancer	0.000597	0.00179	CcSEcCtD
Famotidine—Constipation—Epirubicin—bone cancer	0.000597	0.00179	CcSEcCtD
Famotidine—Urticaria—Methotrexate—bone cancer	0.000593	0.00178	CcSEcCtD
Famotidine—Body temperature increased—Methotrexate—bone cancer	0.00059	0.00177	CcSEcCtD
Famotidine—Abdominal pain—Methotrexate—bone cancer	0.00059	0.00177	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000589	0.00177	CcSEcCtD
Famotidine—Insomnia—Doxorubicin—bone cancer	0.000585	0.00175	CcSEcCtD
Famotidine—Paraesthesia—Doxorubicin—bone cancer	0.00058	0.00174	CcSEcCtD
Famotidine—Feeling abnormal—Epirubicin—bone cancer	0.000576	0.00173	CcSEcCtD
Famotidine—Somnolence—Doxorubicin—bone cancer	0.000575	0.00172	CcSEcCtD
Famotidine—Gastrointestinal pain—Epirubicin—bone cancer	0.000571	0.00171	CcSEcCtD
Famotidine—Dyspepsia—Doxorubicin—bone cancer	0.000569	0.00171	CcSEcCtD
Famotidine—Decreased appetite—Doxorubicin—bone cancer	0.000562	0.00169	CcSEcCtD
Famotidine—Fatigue—Doxorubicin—bone cancer	0.000557	0.00167	CcSEcCtD
Famotidine—Urticaria—Epirubicin—bone cancer	0.000555	0.00166	CcSEcCtD
Famotidine—Pain—Doxorubicin—bone cancer	0.000553	0.00166	CcSEcCtD
Famotidine—Constipation—Doxorubicin—bone cancer	0.000553	0.00166	CcSEcCtD
Famotidine—Abdominal pain—Epirubicin—bone cancer	0.000552	0.00166	CcSEcCtD
Famotidine—Body temperature increased—Epirubicin—bone cancer	0.000552	0.00166	CcSEcCtD
Famotidine—Hypersensitivity—Methotrexate—bone cancer	0.00055	0.00165	CcSEcCtD
Famotidine—Asthenia—Methotrexate—bone cancer	0.000536	0.00161	CcSEcCtD
Famotidine—Feeling abnormal—Doxorubicin—bone cancer	0.000533	0.0016	CcSEcCtD
Famotidine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000529	0.00159	CcSEcCtD
Famotidine—Pruritus—Methotrexate—bone cancer	0.000528	0.00158	CcSEcCtD
Famotidine—Hypersensitivity—Epirubicin—bone cancer	0.000515	0.00154	CcSEcCtD
Famotidine—Urticaria—Doxorubicin—bone cancer	0.000514	0.00154	CcSEcCtD
Famotidine—Abdominal pain—Doxorubicin—bone cancer	0.000511	0.00153	CcSEcCtD
Famotidine—Body temperature increased—Doxorubicin—bone cancer	0.000511	0.00153	CcSEcCtD
Famotidine—Diarrhoea—Methotrexate—bone cancer	0.000511	0.00153	CcSEcCtD
Famotidine—Asthenia—Epirubicin—bone cancer	0.000501	0.0015	CcSEcCtD
Famotidine—Pruritus—Epirubicin—bone cancer	0.000494	0.00148	CcSEcCtD
Famotidine—Dizziness—Methotrexate—bone cancer	0.000494	0.00148	CcSEcCtD
Famotidine—Diarrhoea—Epirubicin—bone cancer	0.000478	0.00143	CcSEcCtD
Famotidine—Hypersensitivity—Doxorubicin—bone cancer	0.000476	0.00143	CcSEcCtD
Famotidine—Vomiting—Methotrexate—bone cancer	0.000475	0.00142	CcSEcCtD
Famotidine—Rash—Methotrexate—bone cancer	0.000471	0.00141	CcSEcCtD
Famotidine—Dermatitis—Methotrexate—bone cancer	0.00047	0.00141	CcSEcCtD
Famotidine—Headache—Methotrexate—bone cancer	0.000468	0.0014	CcSEcCtD
Famotidine—Asthenia—Doxorubicin—bone cancer	0.000464	0.00139	CcSEcCtD
Famotidine—Dizziness—Epirubicin—bone cancer	0.000462	0.00139	CcSEcCtD
Famotidine—Pruritus—Doxorubicin—bone cancer	0.000457	0.00137	CcSEcCtD
Famotidine—Vomiting—Epirubicin—bone cancer	0.000444	0.00133	CcSEcCtD
Famotidine—Nausea—Methotrexate—bone cancer	0.000443	0.00133	CcSEcCtD
Famotidine—Diarrhoea—Doxorubicin—bone cancer	0.000442	0.00133	CcSEcCtD
Famotidine—Rash—Epirubicin—bone cancer	0.00044	0.00132	CcSEcCtD
Famotidine—Dermatitis—Epirubicin—bone cancer	0.00044	0.00132	CcSEcCtD
Famotidine—Headache—Epirubicin—bone cancer	0.000438	0.00131	CcSEcCtD
Famotidine—Dizziness—Doxorubicin—bone cancer	0.000427	0.00128	CcSEcCtD
Famotidine—Nausea—Epirubicin—bone cancer	0.000415	0.00124	CcSEcCtD
Famotidine—Vomiting—Doxorubicin—bone cancer	0.000411	0.00123	CcSEcCtD
Famotidine—Rash—Doxorubicin—bone cancer	0.000408	0.00122	CcSEcCtD
Famotidine—Dermatitis—Doxorubicin—bone cancer	0.000407	0.00122	CcSEcCtD
Famotidine—Headache—Doxorubicin—bone cancer	0.000405	0.00121	CcSEcCtD
Famotidine—Nausea—Doxorubicin—bone cancer	0.000384	0.00115	CcSEcCtD
